(TEACH) Atemtuzumab, Costimulation Blockade and Sirolimus: A Tolerogenic Canvas for Donor Antigen Delivery via Mesenchymal

Administered By

Awarded By

Contributors

Start/End

  • October 1, 2014 - July 31, 2018